Navigation Links
Exagen Diagnostics Appoints New Board Member

ALBUQUERQUE, N.M., Oct. 28, 2013 /PRNewswire/ -- Exagen Diagnostics, a leading medical diagnostic company focused in rheumatology, today announced the addition of Arthur Weinstein, M.D., MACR, FRCP, as its newest board member and adviser to Exagen's scientific team.


Dr. Weinstein is professor of medicine at Georgetown University Medical Center and Associate Chairman, Department of Medicine, and Director, Section of Rheumatology, at MedStar Washington Hospital Center. He is board certified in rheumatology and diagnostic immunology. He attended medical school at the University of Toronto and trained in internal medicine and rheumatology in Toronto and at the Hammersmith Hospital in London. Dr. Weinstein has held faculty positions at medical schools in Toronto and the United States and has been elected a Master of the American College of Rheumatology (MACR) and a Fellow of the Royal College of Physicians (FRCP) of the United Kingdom.

Dr. Weinstein's areas of interest include clinical, laboratory and treatment studies in SLE (Systemic Lupus Erythematosus), as well as Lyme disease, rheumatoid arthritis and connective tissue diseases.  He has authored/co-authored over 100 clinical and research papers and chapters. Some of his earliest studies related to complement metabolism and the usefulness of complement in the diagnosis of SLE.

Dr. Weinstein has helped train more than 50 rheumatologists in the United States and abroad and has volunteered for many nonprofit organizations, including the American College of Rheumatology, Arthritis Foundation, Canadian Arthritis Society, National Institutes of Health, Centers for Disease Control and Prevention, and the Lupus Foundation of America (LFA).  He has been involved in the formation and expansion of lupus clinics in many hospitals, has been chairman of the LFA-DC/MD/VA Medical Scientific Advisory Council and is currently co-chair of its board of directors.  In 2008, Dr. Weinstein was recognized by the LFA as Volunteer of the Year.

"We are honored to have Dr. Weinstein on the board due to his extensive strategic and clinical experience in rheumatology and autoimmune disease," stated Ron Rocca, Exagen president and CEO. "With his valuable input, we will continue to develop meaningful clinical diagnostic tests to assist rheumatologists in improving patient outcomes."

About Exagen
Exagen Diagnostics, Inc. is a patient focused, discovery driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the areas of rheumatology and autoimmune diseases. Committed to Personalized Medicine, our tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information, please visit

SOURCE Exagen Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Unveils Future Opportunities for the Tissue Diagnostics Market
2. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
3. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
4. Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement
5. Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
6. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
7. Aging to Be Reversed through Revolutionary New Category of Diagnostics
8. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
9. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
10. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
11. Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) -- Technology Trend Analysis -- By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis -- Estimates up to 2018
Post Your Comments:
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ... "Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise ... the Demand " report to their offering. ... --> Boston scientific and others. ... players including Medtronic, Biotronik, Boston scientific ...
(Date:11/26/2015)... 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ... kidney transplantation is expected to boost the market growth, as ... transplantation. --> 3D bioprinting market is expected ... new report by Grand View Research Inc. Rising prevalence of ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Japanese therapeutic drug monitoring market, including emerging ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think ... customers choose to buy during the Black Friday and Cyber Monday massage chair ... to search the Internet high and low to find the best massage chair deals, ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced ... franchise owner, Somu now offers travelers, value and care based Travel Services, including ... sales, as well as, cabin upgrades and special amenities such as, shore excursions, ...
(Date:11/26/2015)... ... November 26, 2015 , ... The ... bioavailability and the need to integrate dose form selection in early phase drug ... the membership organization supporting and bringing together the UK’s emerging life sciences companies, ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
Breaking Medicine News(10 mins):